Crinetics Pharmaceuticals Inc
NASDAQ:CRNX

Watchlist Manager
Crinetics Pharmaceuticals Inc Logo
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Watchlist
Price: 50.49 USD 2.39% Market Closed
Market Cap: 4.8B USD

Wall Street
Price Targets

CRNX Price Targets Summary
Crinetics Pharmaceuticals Inc

Wall Street analysts forecast CRNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRNX is 81.75 USD with a low forecast of 45.45 USD and a high forecast of 113.4 USD.

Lowest
Price Target
45.45 USD
10% Downside
Average
Price Target
81.75 USD
62% Upside
Highest
Price Target
113.4 USD
125% Upside
Crinetics Pharmaceuticals Inc Competitors:
Price Targets
ACAD
ACADIA Pharmaceuticals Inc
10% Upside
BIOPOR
Bioporto A/S
281% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
35% Upside
PBYI
Puma Biotechnology Inc
19% Downside
603087
Gan & Lee Pharmaceuticals
2% Downside
MRSN
Mersana Therapeutics Inc
19% Upside
CMPX
Compass Therapeutics Inc.
143% Upside
MDXG
MiMedx Group Inc
72% Upside

Revenue
Forecast

Revenue Estimate
Crinetics Pharmaceuticals Inc

For the last 7 years the compound annual growth rate for Crinetics Pharmaceuticals Inc's revenue is -9%. The projected CAGR for the next 4 years is 380%.

-9%
Past Growth
380%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Crinetics Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Crinetics Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRNX's stock price target?
Price Target
81.75 USD

According to Wall Street analysts, the average 1-year price target for CRNX is 81.75 USD with a low forecast of 45.45 USD and a high forecast of 113.4 USD.

What is Crinetics Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
380%

For the last 7 years the compound annual growth rate for Crinetics Pharmaceuticals Inc's revenue is -9%. The projected CAGR for the next 4 years is 380%.

Back to Top